M&A Deal Summary

Meridian Bioscience Acquires Viral Antigens

On September 27, 2000, Meridian Bioscience acquired medical products company Viral Antigens for 9M USD

Acquisition Highlights
  • This is Meridian Bioscience’s 2nd transaction in the Medical Products sector.
  • This is Meridian Bioscience’s 5th largest (disclosed) transaction.
  • This is Meridian Bioscience’s 2nd transaction in the United States.
  • This is Meridian Bioscience’s 1st transaction in Tennessee.

M&A Deal Summary

Date 2000-09-27
Target Viral Antigens
Sector Medical Products
Buyer(s) Meridian Bioscience
Deal Type Add-on Acquisition
Deal Value 9M USD

Target

Viral Antigens

Memphis, Tennessee, United States
Viral Antigens, Inc. is a manufacturers of custom and specialty viral reagents for human infectious disease.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Meridian Bioscience

Cincinnati, Ohio, United States

Category Company
Founded 1976
Sector Life Science
Employees702
Revenue 318M USD (2021)
DESCRIPTION

Meridian is a life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Meridian was founded in 1976 and is based in Cincinnati, Ohio.


DEAL STATS #
Overall 2 of 11
Sector (Medical Products) 2 of 5
Type (Add-on Acquisition) 2 of 7
State (Tennessee) 1 of 1
Country (United States) 2 of 8
Year (2000) 1 of 1
Size (of disclosed) 5 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1998-11-06 Gull Laboratories

Salt Lake City, Utah, United States

Gull Laboratories, Inc. manufactures medical products in US.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-01 O.E.M. Concepts

Saco, Michigan, United States

O.E.M. Concepts, Inc. is a producer and distributor of biological components.

Buy $6M